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Abstract 
 
Antibody-secreting plasma cells (PC) arise rapidly during adaptive immunity to 
control infections. The early PC are retained within the reactive lymphoid organ 
where their localization and homeostasis relies on extrinsic factors, presumably 
produced by local niche cells. While myeloid cells have been proposed to form those 
niches, the contribution by co-localizing stromal cells has remained unclear. Here, we 
characterized a subset of fibroblastic reticular cells (FRC) that forms a dense 
meshwork throughout medullary cords of lymph nodes (LN) where PC reside. This 
medullary FRC type is shown to be anatomically, phenotypically and functionally 
distinct from T zone FRC, both in mice and humans.  By using static and dynamic 
imaging approaches, we provide evidence that medullary FRC are the main cell type 
in contact with PC guiding them in their migration. Medullary FRC also represent a 
major local source of the PC survival factors IL-6, BAFF and CXCL12, besides 
producing also APRIL. In vitro, medullary FRC alone or in combination with 
macrophages promote PC survival while other LN cell types do not have this 
property. Thus, we propose that this new FRC subset, together with medullary 
macrophages, forms PC survival niches within the LN medulla, and thereby helps 
promoting the rapid development of humoral immunity which is critical in limiting 
early pathogen spread.  
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Significance statement: 
Lymph nodes are sites where adaptive immunity is initiated, leading to the generation 
of plasma cells secreting large amounts of antibodies that typically interfere with 
pathogen spread. Plasma cells are known to depend on extrinsic factors provided by 
niche cells to stay alive; however, the critical niche cells are still poorly understood. 
Here we present evidence for a new fibroblast subset within murine and human 
lymph nodes that is unique to the medulla where plasma cells reside. These 
fibroblasts produce factors that positively regulate plasma cell homeostasis, similar to 
macrophages. Knowing the critical niche cells may help to design intervention 
strategies to target this niche in the setting of autoimmune disease caused by plasma 
cells secreting autoreactive antibodies.  
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“/body” 
INTRODUCTION 
 
Lymph nodes (LN) are specialized organs filtering lymph fluid and inducing adaptive 
immunity to antigens derived from pathogens, tumors or vaccines. They are 
composed of different regions, each populated by distinct resident stromal cells, 
including follicular dendritic cells (FDC), that attract recirculating B cells into follicles, 
and fibroblastic reticular cells (FRC), that attract recirculating T cells and mature 
dendritic cells (DC) into the paracortex (1, 2). The third compartment - the medulla - 
is a site of plasma cell (PC) residence and antibody secretion. So far, the stromal 
organizer cell of that zone has been poorly characterized.  
PC responses are crucial for systemic antibody-mediated protection upon infection, 
and are the main success reason of current vaccines. Upon B cell activation within 
LN, two anatomical niches critical for an efficient humoral response develop: PC foci 
within medullary cords (MC) and germinal centers (GC) within follicles (3, 4). The 
extrafollicular B cell differentiation within MC allows rapid antibody responses to limit 
systemic spread of replicating pathogens. Typically, within 2-4 days after infection, 
proliferating plasmablasts (PB) are observed in outer T zones which differentiate into 
PC that take residence within MC and secrete large quantities of antibodies. This 
early humoral response of lower affinity usually lasts few days with only a small 
fraction of PC surviving several weeks (3, 4). In contrast, the follicular B cell 
differentiation within GC allows the generation of memory B cells and PC of high 
affinity, with PC exiting the LN and homing to sites like the bone marrow (BM), where 
they can survive over months and provide long-term humoral protection starting 
around day 10-14 after immunization (4, 5).  
PC isolated from BM, LN and spleen are mostly short-lived when placed in vitro (6, 7), 
raising the question about the critical support cells providing extrinsic survival signals 
in vivo.  The prevailing view is that myeloid cells, including macrophages, DC and 
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granulocytes, mediate PC survival within activated LN and spleen (4, 8). This is 
based both on evidence of co-localization in PC-rich areas and expression of factors 
which can increase PC survival in vitro, including BAFF, APRIL, IL-6 and CXCL12 (4, 
6, 8). However, myeloid cells were found to be a minor source of BAFF and CXCL12 
in vivo (8), consistent with an important role for non-hematopoietic cells as BAFF 
source in the extrafollicular PC response (9). In addition, in vivo cell depletion 
experiments showed that myeloid cells have either a positive role (10), no role (11) or 
even a negative role in extrafollicular PC development (12). 
In the BM, fibroblasts form part of the survival niche for long-lived PC by producing 
IL-6 and CXCL12, along with hematopoietic cell types contributing BAFF and APRIL 
(4). Poorly characterized fibroblasts from LN and spleen in mice and men were also 
shown to promote PC survival in vitro (7, 13-15), raising the possibility that FRC-like 
cells within MC may contribute to PC homeostasis.  
FRC expressing podoplanin (pdpn, also known as gp38) are found in all three 
peripheral LN (pLN) compartments, produce extracellular matrix (ECM) proteins and 
are heterogeneous in their localization, morphology and function (1, 16). T zone FRC 
(TRC) are the largest and best studied subset, forming a 3-dimensional cell network 
which physically guides lymphocyte migration (17). They support T cell function 
through the secretion of the survival factor IL-7 and the chemokines CCL19 and 
CCL21, responsible for T cell and DC attraction, motility and retention within T zones 
(2, 16). TRC wrap around a matrix-based tube system, called conduits, used for 
intranodal transport of lymph fluid and small molecules (18). Within follicles two 
additional FRC subsets were described that express the naïve B cell survival factor 
BAFF and the B cell attractant CXCL13: MAdCAM+ marginal reticular cells (MRC) 
localizing in the subcapsular region (19), and MAdCAM- FRC in the outer follicle (20, 
21). FRC depletion experiments have shown that lymphocyte responses cannot be 
induced efficiently in the absence of FRC (22). Together, these data demonstrate 
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that distinct FRC types act as organizer cells of microenvironments found within the 
B and T zone, and thereby play a critical role in adaptive immunity. 
Given that matrix fibers and pdpn+ FRC-like cells have been observed by histology 
within MC by us and others (10, 18, 23-25), we hypothesized that a specialized FRC 
subset may serve as the missing positive regulator of local PC niches. Here, we have 
performed a detailed histological and functional analysis of FRC subsets within 
activated LN. We report the identification of medullary FRC (MedRC) along with the 
characterization of their unique morphological, molecular and functional properties. 
Importantly, using histological and functional assays we demonstrate that MedRC 
are a major structural component of the PC niche in the medulla guiding PC 
migration and residence, but also a potent source of PC attraction and survival 
factors.  
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RESULTS 
Histological identification of medullary FRC in murine and human LN  
To generate a strong PC accumulation within LN, mice were immunized s.c. with 
ovalbumin (OVA) protein in Montanide (Mont) adjuvant. 5-8 days later strongly 
enlarged medullary areas were observed, composed of LYVE1+ medullary sinuses 
(MS) and MC enriched in CD138+ PC, but only few scattered B and T cells (Fig. 1A-
B). Networks of pdpn+ desmin+ FRC and laminin+ matrix structures were not only 
observed throughout T zones but also within MC, often organizing around CD31+ 
HEV (Fig. 1B-C; SI Appendix Fig. S1A). Similar to TRC, reticular cells of the MC 
express desmin, SMA and LT-receptor (SI Appendix Fig. S1B). CD11b+ or CD169+ 
macrophages were predominantly seen within MS, with some being inside MC (Fig. 
1C). When screening various stromal cell antibodies we noted that BP3 (CD157) 
labels both MRC and TRC, but not MedRC (Fig. 1D; SI Appendix Fig. S1C), while 
MAdCAM-1 marks only MRC in naïve and activated lymph nodes. Thus, the 
combination of MAdCAM-1 and BP3 allows the distinction of MedRC from TRC and 
MRC in murine LN. CD34, however, marks only a subset of MedRC found close to 
medullary blood vessels (SI Appendix Fig. S1D). 
Next, we assessed whether in human reactive LN sections these stromal cell 
markers would identify a similar MedRC subset colocalizing with PC. Medullary 
regions were readily observed, displaying MC densely populated by nucleated cells 
and centered around CD31+ blood vessels while being surrounded by LYVE1+ MS 
harboring few cells in the lumen (Fig. 1E). CD138+ PC localize preferentially to the 
MC, clearly separated from most T and B cells. As expected (26), pdpn shows the 
strongest expression on TRC, which were CD21-, while FDC co-express pdpn and 
CD21 (Fig. 1F). Within MC, pdpn labels reticular cells, as well as vascular cells 
expressing CD31 and/or LYVE1 (Fig. 1E). In contrast to the mouse, BP3 expression 
is highest in the medulla, intermediate on TRC and low on FDC (Fig. 1F; SI Appendix 
Fig. S1E). Within MC, BP3 expression was observed on a dense reticular cell 
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network that partially co-localizes with pdpn+ cells. Consistent with them being 
fibroblastic cells, MC regions display collagen-I and laminin-expressing reticular 
fibers. They are part of the PC niche (Fig. 1G), as are CD11c+ DC and lysozyme+ 
macrophages/granulocytes (SI Appendix Fig. S1F). Thus, the PC niche composition 
in human LN medulla closely resembles the one observed in mice. 
 
Identification of medullary FRC by flow cytometry 
Next, the surface markers MAdCAM-1 and BP3 were tested by flow cytometry on 
CD45-35-31-pdpn+ FRC isolated from murine LN. Three FRC subsets were observed 
in both naive and activated LN, with MAdCAM+BP3+ MRC representing 5-10%, 
MAdCAM-BP3+ TRC representing 50-65%, and MAdCAM-BP3- MedRC 20-35% of 
isolated FRC (Fig. 2A). During immune response only MRC slightly increased in 
proportion, with all subsets increasing 4-fold in number and 40-80% of cells having 
incorporated BrdU (Fig. 2B-C; SI Appendix Fig. S2A-B).  
Given the distinct immune cell composition in MC we reasoned that MedRC should 
be functionally different from CCL21+ TRC and CXCL13+ MRC. Indeed, MedRC from 
both naive and activated LN showed very little intracellular CCL21 protein, while 
many TRC from wild type (wt), but not CCL19/21ser-deficient plt/plt mice, were 
CCL21+ (Fig. 2D; SI Appendix Fig. S2C). While some MRC-like cells express CCL21, 
other MRC showed higher CXCL13 expression than TRC, with MedRC being 
CXCL13-. This chemokine expression pattern was largely maintained during the 
immune response (SI Appendix Fig. S2D). These findings were confirmed in sorted 
cells at the transcriptional level. ccl21 and cxcl13 mRNA were highest in TRC and 
MRC of naive and activated LN, as were ccl19 and il7 (Fig. 2E; SI Appendix Fig. 
S2E). Importantly, MedRC had at least 10-fold lower levels of these four cytokine 
transcripts. In contrast, cxcl12 was expressed mainly by MedRC and TRC. Sorted 
lymphatic and blood endothelial cells (LEC/BEC), however, did not show much 
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expression for any of these cytokines. These qRT-PCR data corroborate with in situ 
hybridization (ISH) analysis, showing the very modest expression levels of ccl21, 
cxcl13 and ccl19 transcripts within MC, while cxcl12 transcripts were found to be at 
levels comparable to the T zone (Fig. 2F; SI Appendix Fig. S2F). Histological staining 
for chemokine proteins confirmed the lack of CCL21 and CXCL13 within MC, while 
CXCL12 was readily detected, both in MC and T zones, and frequently co-localizing 
with reticular pdpn+ FRC (Fig. 2G). Thus, our data demonstrate that MedRC are 
anatomically, phenotypically and functionally distinct from TRC and MRC. 
Multiparameter analysis by flow cytometry confirm this notion, and indicate an even 
greater diversity of pdpn+ fibroblastic LN cells than previously anticipated, with a 
continuum of 7 phenotypically different FRC populations (Fig. 2H and S2G), which do 
not include FDC and pdpn-CD31- populations. 
  
MedRC and TRC generate different extracellular matrix (ECM) structures 
TRC produce functional conduits that they enwrap but it is not known whether similar 
features apply to MedRC. We observed a reticular staining for collagen I and IV as 
well as fibronectin, often in thinner structures than inside T zones but often co-
localizing with pdpn+ MedRC (Fig. 3A). Consistent with these findings, all three FRC 
subsets express high levels of collagen11 and collagen12 transcripts, with a 
marked increase after immunization, especially in MedRC (Fig. 3B). Given the high 
specificity of collagen 1 expression for fibroblasts, we used transgenic mice 
expressing GFP under control of the collagen 11 promoter (pCol-GFP) (27) to 
visualize FRC in vivo. In activated LN, a reticular GFP expression was clearly visible, 
being strongest in MC, intermediate inside T zones and absent in the center of 
follicles (Fig. 3C). By histology and flow cytometry GFP expression is largely 
restricted to the three FRC subsets (SI Appendix Fig. S3A-D). Similar to GFP 
expression, histological PDGFR staining was stronger on MedRC than TRC, while 
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BP3 and CCL21 showed the opposite pattern (Fig. 3D; SI Appendix Fig. S3D-G). 
This segregation was reflected in the lymphocyte distribution, with T cells co-
localizing with CCL21+ TRC and scattered B cells found among MedRC (SI Appendix 
Fig. S3D, F). 
The increased GFP signal detected by fluorescence microscopy in MC relative to T 
zones correlated with a 2-fold higher FRC density and a therefore reduced spacing 
between FRC processes (Fig. 3E; SI Appendix Fig. S3E). In addition, MedRC display 
less elongated cell bodies and thinner cell processes than TRC (Fig. 3E). Similar to 
the collagen I staining, second harmonic generation (SHG) revealed differences in 
the fibrillar collagen organization. In the medulla, thick and wavy collagen bundles 
alternate with very thin fibers, while in T zones collagen fibers display a more linear 
and regular organization (Fig. 3 F-G; SI Appendix Movie S1). Interestingly, MedRC 
enwrapped less the matrix structures than did TRC (Fig. 3G). To test conduit function, 
fluorescent dextran was injected subcutaneously. While most tracer localized to 
LYVE1+ MS and to T zone conduits, a thin reticular pattern was apparent in MC, 
overlapping with collagen IV staining (Fig. 3H; SI Appendix Fig. S3H). In conclusion, 
MedRC build a very dense cell network that is only partially associated with an 
equally dense but functional conduit network. 
 
Medullary FRC show extensive contacts with PC 
Next, we compared the relative contribution of hematopoietic cells versus MedRC to 
the PC niche. Numerous macrophages (F4/80+, CD11b+ or CD169+), DC (CD11c+, 
MHCII+) and B220+ B cells are present in MC and show direct PC contact, while the 
frequency of granulocytes (Gr1hi) is much lower (Fig. 4A; SI Appendix Fig. S4A). 
MedRC were observed in MC in a similar density as macrophages (SI Appendix Fig. 
S4B).  While 60-70% of PC physically interacted with macrophages and B cells, 
almost 100% of PC contacted GFP+ MedRC (Fig. 4A). The latter finding was 
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confirmed and extended using 3D confocal image stacks, where on average 25% of 
the PC surface was found to physically touch MedRC, often at multiple points (SI 
Appendix Fig. S4C; SI Appendix Movie S2). Despite forming a dense network in MC, 
MedRC do not contact all cells equally, as only 70% of B220+ cells contact them, in 
contrast to 100% of PC and F4/80+ cells (SI Appendix Fig. S4D).  
To gain insight into the dynamics of PC interactions with MedRC, labeled PC 
(CD138+B220low) or PB (CD138+B220int) were added on top of viable tissue slices of 
activated LN from pCol-GFP mice. Most PB migrated preferentially into the MC 
where endogenous CD138+ PC resided (SI Appendix Fig. S4E). As previously 
reported (28), PB showed higher motility than PC, more prominently within the outer 
T zone than the MC, and this migration was largely unaffected by pertussis toxin, 
which blocks most chemokine-based cell migration. Next, endogenous PC/PB within 
viable LN slices were antibody-labeled to image their dynamic interaction with GFP+ 
FRC. In the outer T zone, PB moved rapidly and often in long linear tracks, thereby 
following the TRC network, going from one TRC to the next, but with no directional 
bias toward MC (Fig. 4B-C and S4F; Movies S3-4). In contrast, PC in MC showed 
much slower and confined migration with limited displacement (Fig. 4B-C; SI 
Appendix Movie S5). Consequently, PC interactions with each MedRC were 
considerably longer, changes from one MedRC to the other less frequent, and 
contact always continuous. MedRC frequently showed pronounced morphological 
changes, in contrast to the more static TRC (SI Appendix Movie S6), possibly due to 
the difference in matrix association. Collectively, these data show that MedRC 
physically guide PC migration and residence, by providing both a cellular network 
and niche-like structures.  
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Medullary FRC are a rich source of plasma cell survival factors 
To look for the potential expression of PC survival factors by MedRC, they were 
sorted along with seven other cell types. Strikingly, on d5 and d8 activated LN baff 
transcripts were 40-100fold more abundant in the three FRC subsets than in 
macrophages and DC, with rare granulocytes showing intermediate levels (Fig. 5A; 
SI Appendix Fig. S5A, B). In contrast, april transcript levels were similar among FRC 
subsets, macrophages and DC. Il6 transcripts were 10-20fold higher in MedRC than 
in other FRC subsets and myeloid cells. Finally, Cxcl12 was highly enriched in the 
three FRC subsets. Surprisingly, expression of these four cytokines were similar in 
cells sorted from activated versus naïve LN (SI Appendix Fig. S5B), pointing to an 
increase in the number of expressing cells rather than expression levels.  
Given that we saw a preferential expression of BAFF and IL-6 transcripts in FRC, 
especially MedRC, we wished to localize them in sections of activated LN, similar to 
our previous analysis for CXCL12 (Fig. 2F, G).  BAFF protein staining of activated wt 
LN was strongest within MC, with lower expression detectable within T and B zones. 
Part of the medullary BAFF colocalized with pdpn+ FRC. To identify the BAFF source 
more precisely, activated LN of mice transgenic for a non-cleavable BAFF were 
investigated. Strikingly, the BAFF staining was much stronger than in wt LN, with 
highest levels on pdpn+/desmin+ MedRC and TRC (Fig.s 5B and S5C-D). IL-6 
transcripts were also abundantly present within MC, besides their expression in B 
and T zones (Fig. 5C). To further define the cellular sources of IL-6 and BAFF at the 
protein level, various cell types were sorted, cultured and assessed by ELISA.  Ex 
vivo MedRC proved to be the richest source of IL-6 protein when compared with TRC, 
macrophages and DC (Fig. 5D). In contrast, we failed to detect secreted or surface 
bound BAFF. Thus, our results suggest that within the PC niche MedRC are a major 
source of IL-6, BAFF and CXCL12, with hematopoietic cells contributing only APRIL 
and possibly IL-6 at comparable levels. 
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IL-6 is important for plasma cell differentiation or survival in peripheral LN 
Given the predominant IL-6 expression by MedRC, we tested the in vivo role of IL-6 
for the extrafollicular PC response. IL-6 competent splenocytes from OT-I and OT-II 
TCR tg mice were transferred into IL-6 deficient mice followed by OVA/Mont 
immunization, which allowed a normal T cell expansion (SI Appendix Fig. S6A). On 
d5.5 and d8.5 after immunization, PB/PC numbers in the draining LN were reduced 
by 60% in IL-6 KO mice relative to controls (Fig. 6A; SI Appendix Fig. S6A). This 
result cannot be explained by altered B cell development in IL-6 KO mice, because 
transferred wt B cells showed a similar reduction in local PB/PC differentiation as IL6-
/- B cells. We noted a marked reduction in various stromal cells within activated LN, 
including MedRC but not TRC, suggesting that IL-6 directly or indirectly regulates the 
number of MC niches (SI Appendix Fig. S6B). OVA-specific IgM and IgG levels in the 
serum were approximately 2-fold reduced in IL-6 deficient mice (SI Appendix Fig. 
S6C). Strikingly, OVA-specific IgG produced in cultures from IL-6 deficient LN were 
almost 10-fold reduced at both time points investigated and correlated well with the 
rare occurrence of IgG+ PB/PC, while the local IgM response was poorly affected (Fig. 
6A-B). This striking scarcity of IgG+ PC raised the possibility that PC in IL-6 KO mice 
have defects either in their migration or retention in MC, where they complete their 
maturation into PC, or in their survival. In IL-6-/- mice, the localization and clustering 
of CD138+ PC next to MedRC was unaltered (SI Appendix Fig. S6D). Similarly, IL-6 
neutralization had no effect on endogenous PC localization in MC and no or minor 
effects on their velocity and spatial displacement (Fig. 6C-D; SI Appendix Movie S7). 
Thus, IL-6 may primarily serve as factor driving the development and/or survival of 
PB/PC, including possibly a role in isotype switching.  
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Medullary FRC and macrophages promote PC survival via IL-6 production 
Genetic tools to selectively manipulate MedRC in vivo are currently lacking. 
Therefore, we turned to in vitro co-culture assays to test whether MedRC and innate 
immune cells are capable of regulating PB/PC homeostasis. While all purified PB/PC 
died when cultured alone for 3 days, 10-20% of PB/PC were rescued in presence of 
FRC isolated from activated LN to an extent similar to recombinant IL-6 (Fig. 7A). 
This PB/PC rescue involved very little PB proliferation in vitro (SI Appendix Fig. S7A) 
indicating that this assay is mainly a readout for PC survival. PC numbers were 
preserved when PC were separated from FRC by a transwell filter, or when PC were 
cultured with FRC conditioned medium, suggesting the survival factor is soluble 
rather than membrane-bound (Fig. 7A).  FRC-mediated PC survival was blocked 
almost entirely by IL-6 neutralizing antibodies but not by inhibitors of BAFF, APRIL or 
CXCL12 (SI Appendix Fig. S7B). However, a marked drop in baff, april and cxcl12 
expression was noted in cultured FRC, with minor effects for IL-6, which may be lost 
later on, as indicated by the low levels observed in the FRC line pLN2 (SI Appendix 
Fig. S7C). Next, the various LN cell types were FACS-sorted and tested in their 
capacity to mediate PC survival. MedRC and macrophages were much more efficient 
in mediating PC survival compared to sorted TRC and DC, with no PC survival 
observed in LEC/BEC or T/B lymphocyte co-cultures (Fig. 7B). PC survival by 
MedRC, macrophages or DC was almost exclusively mediated by IL-6, as was their 
capacity to boost IgM and, more impressively, IgG production (Fig. 7C, D). 
Combining the various cell types, each in suboptimal numbers, showed synergistic 
effects on PC survival and additive effects on IgG but not IgM secretion, with most of 
the effects mediated by IL-6 (Fig. 7E; SI Appendix Fig. S7D). Interestingly, MedRC 
seem to be more efficient in promoting IgM/G secretion by PC than macrophages or 
DC, also indicating that PC survival is not predictive of Ig secretion levels which may 
depend on high IL-6 levels or additional factors. Collectively, these data demonstrate 
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that MedRC - together with myeloid cells - not only form physical niches for PC, but 
also secrete factors capable of mediating PC survival and function. 
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DISCUSSION 
In the current study, we characterized a new fibroblast subset that we termed 
MedRC as it is present as reticular cell network throughout the medullary cords and 
is phenotypically and functionally distinct from TRC and MRC. MedRC form niche-
like structures in which PC and innate immune cells reside. In addition, they are a 
rich source of various factors that can promote PB/PC migration, localization, survival 
and function. We therefore propose that MedRC are an important component of PC 
niches inside LN and thereby positively regulate early humoral immunity. 
The combination of two surface markers, MAdCAM and BP3, allowed us to 
distinguish murine MedRC from TRC and MRC. This classification was largely 
confirmed by intracellular staining for CCL21 and CXCL13 proteins that were absent 
in MedRC, but allowed a further functional subdivision of TRC and MRC at the single 
cell level. Around 60% of TRC express CCL21, consistent with previous observations 
(10, 20, 29, 30). TRC also comprise around 15% CXCL13+CCL21- cells, explaining 
the high level of cxcl13 transcripts observed by us and others among pdpn+ FRC (20, 
31), as well as cxcl13 expression still found in follicles of FDC-depleted mice (32). 
Given the follicular localization of CXCL13 protein, these cells are likely to reside in 
the outer B cell follicle (21) and possibly co-express BAFF (22), the Notch-ligand DL-
4 (33) and enzymes generating the chemoattractant oxysterol (20). We propose to 
call them ‘B zone reticular cells’ (BRC)(SI Appendix Fig. S7E). Our unbiased flow 
cytometric clustering analysis (TSNe) points to a total of at least 7 phenotypically 
distinct fibroblast-like cell types inside LN, not including the different CD35+ FDC 
types and Pdpn-CD31- (double negative or DN) fibroblastic cells that were gated out 
from this analysis. Notably, these 7 cell clusters appear to form a continuum that 
could reflect the zones as well as transitions between zones where specific 
processes, such as T-B collaboration or PB differentiation may occur (2, 34). A 
recent report based on single cell RNA sequencing of lymph node fibroblasts points 
to nine transcriptionally distinct populations, including the Inmt+ stromal cells which 
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most likely correspond to our MedRC subset (35). The exploration of these 
presumably different cell types or cell states, their relationship and regulation as well 
as their respective function will be an important area for the future.  
 
The MedRC subset described here is number-wise a relatively large population 
within naïve and activated LN and has previously been considered together with their 
T zone counterpart. They include as a subset the recently described CD34+ 
perivascular FRC with precursor potential (30, 35). Importantly, MedRC express little 
T and B zone chemokines, while producing CXCL12 at levels comparable to TRC, 
consistent with high CXCL12-reporter expression in most LN FRC (24). Given the 
prevalence of CXCL12 expression in sorted MedRC compared to other MC cell types, 
along with the lacking expression in innate immune cells (8), we propose that MedRC 
are the major local source of this chemokine along with blood vessels (24). MedRC 
may therefore contribute to the medullary localization of CXCR4+ cells which do not 
express much CCR7 and CXCR5, including PC (2, 14), granulocytes and 
macrophages, thereby generating the distinct cellular composition of MC. CXCR4-/- 
PB/PC fail to localize appropriately within MC (2), suggesting that cells excluded from 
T and B cell zones need CXCL12 cues to either migrate deeper into the MC or to be 
locally retained in this region. Consistent with it, pertussis toxin treatment of mice 
reduced PC accumulation in MC but most PB migration appeared to be non-
directional, similar to previous evidence (28). In vitro, PB migrate towards CXCL12 
gradients in a pertussis-toxin dependent manner (2, 14). Therefore, we propose that 
PB which have reached the outer T zone are either attracted or retained by the 
CXCL12-expressing MedRC. Additional factors, like accessible matrix fibers enriched 
within MC (36), may also contribute to PB/PC adhesion and retention.  
Fooksman and colleagues have described the persistent linear tracks of PB in the LN 
T zone followed by the slower and much more confined migration of PB/PC once 
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they have reached MC (28, 37). We confirm these findings, and propose that the 
different migration strategy can be explained at least in part by PB/PC being 
physically guided initially by the TRC and later by the MedRC network, similar to the 
reported naïve lymphocyte migration along TRC and FDC (17). The molecular basis 
for this PB crawling along the FRC networks remains to be defined, but may include 
ICAM-1 on FRC (28). While the clearly decreased displacement of PC relative to PB 
is probably due to their terminal differentiation and therefore intrinsic changes, our 
results suggest that both the spatial organization and morphology of MedRC may 
also contribute. The FRC network is denser in MC than T zones. Relative to TRC, 
MedRC are less reticular and more stellate, presumably because they enwrap less 
the matrix fibers (36). This arrangement might impede fast and linear PC migration, 
with the more accessible matrix potentially allowing increased PC adhesion.  
The slow PC motility within MC goes along with the long contact duration and large 
contact zones with MedRC. The cavities of the MedRC network appear tailor-made 
in size for allowing residence and signal recognition by single PC. Therefore, the 
term 'survival niche' seems very appropriate. This niche also includes B220+ B cells 
and myeloid cells, with the role of macrophages and dendritic cells being 
controversially discussed (4, 8, 10-12). We have observed synergistic effects on PC 
survival when combining MedRC with myeloid cells. This is in contrast to 
macrophage depletion experiments showing an enhanced extrafollicular PC 
response (12). We have also performed preliminary experiments to deplete MedRC 
in a CCL19Cre x ROSA-DTR cross (in collaboration with Lucas Onder and Burkhard 
Ludewig). This approach that depleted 50-75% of MedRC was associated with a 30-
50% reduction in PC, and a strong reduction in IgM and IgG secretion by LN-resident 
PC. In addition, PC accumulated within the outer T zone suggesting MedRC and/or 
TRC are important for late B cell differentiation and/or PC survival. However, most 
LN cell types were affected by this depletion, including most TRC and thereby 
presumably also lymphocyte differentiation processes within T zones. Therefore, in 
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future, rather than using depletion systems, mouse models need to be developed to 
selectively ablate expression of PC guidance and survival factors in MedRC versus 
TRC. Despite the current lack of appropriate mouse models, the many lines of 
evidence presented here are all consistent with the notion that MedRC contribute 
significantly to PC niches inside LN, both structurally and functionally. We propose a 
model in which the PC niche is composed of motile hematopoietic cells but also of a 
static fibroblast network (SI Appendix Fig. S7F), reminiscent of bone marrow niches 
for long-lived PC (4, 5). This mixed composition may increase the robustness of the 
humoral response while allowing a more elaborate regulation. Whether fibroblasts 
also contribute to PC-niches in other tissues, including spleen and intestinal lamina 
propria, remains an interesting open question. 
 
IL-6, BAFF, APRIL and CXCL12 can promote PC survival in vitro (3, 4), while less is 
known on their relative role and expression in vivo (24, 38). Analysis of various 
sorted innate cells has failed to identify the source of BAFF and CXCL12 (8) 
consistent with bone marrow chimera experiments pointing to non-hematopoietic 
cells as BAFF source (9). We now provide strong evidence for MedRC being the 
elusive source of both BAFF and CXCL12 within MC, with BAFF expression being 
highly MedRC restricted both at the mRNA and protein level, consistent with a recent 
report (34). This BAFF source is distinct from the less prominent one in the T and B 
zones. BAFF expressed by MedRC is very likely to be sensed by the neighboring PC 
enhancing their survival, while TRC-derived BAFF could contribute to the earlier 
differentiation and survival of B cell blasts. These two roles for BAFF are different 
than the recently proposed one for BRC-derived BAFF in naive B cell survival and 
follicular homeostasis (22). Our attempts at neutralizing BAFF during an ongoing 
response led to only a weak reduction in PC survival, comparable to the one recently 
reported for early PC responses in mice deficient in hematopoietic April or IL-6 (38).  
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Myeloid cells were proposed to be a strong source for IL-6 (8) but surprisingly their 
depletion increased PC numbers (12). We found higher IL-6 expression in MedRC 
than myeloid cells, both at the transcriptional and protein level, similar to a recent 
report (34), with MedRC being slightly more efficient in promoting IgM/G secretion by 
PC, again in an IL-6 dependent manner. While lymphoid tissue fibroblasts were 
known as potent IL-6 source that can mediate survival of PC and hybridoma cells (7, 
14, 15) the fibroblast subset colocalizing with PC has to our knowledge not been 
sorted and tested ex vivo without passaging, as performed in this study.  IL-6 is also 
known to regulate PC responses in vivo. However, previous publications have 
focused on late PC responses which most likely involve germinal center responses 
(6, 39, 40). Here we describe a 50% loss of the early extrafollicular PC generation in 
the absence of IL-6. Our reverse bone marrow chimera experiments using IL-6-/- and 
wt mice have failed to reveal any difference in the contribution of hematopoietic 
versus non-hematopoietic cells. These findings are consistent with our co-cultures, 
where both MedRC and myeloid cells promoted PC responses almost entirely via IL-
6. While these findings establish that IL-6 produced by these cells can positively 
regulate PC survival and function, several signals were lost during culture, including 
BAFF and APRIL. It is also conceivable that the expression of negative regulators by 
myeloid cells was lost upon culture, which would explain the difference with some of 
the in vivo findings (12). Overall, our results are consistent with earlier proposals that 
in vivo PC survival may be controlled by a combination of factors, including IL-6, 
BAFF and APRIL (3, 4). The precise roles of BAFF, APRIL and IL-6 need to be 
further investigated in vivo using cell type-specific knockout mice, but the 
simultaneous presence of several B cell differentiation and PC survival factors as 
well as several niche cell types indicates a potential redundancy and robustness of 
the system (SI Appendix Fig. S7F).  
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While most of our study focused on mouse tissues, we have provided here first 
evidence for a similar fibroblast-based niche in MC of human LN. The markers 
described here and in a previous study (26) to distinguish human fibroblast subsets 
should be useful in future to sort and functionally define these cells, both in LN and 
sites of chronic inflammation where PC have been observed, like in rheumatoid 
arthritis joints or kidneys of lupus patients. Interestingly, in these settings fibroblast-
like cells in the lesions have been established as major source of PC survival factors 
(41, 42), reminiscent of LN MedRC and TRC described in this study. In several B 
cell-mediated autoimmune diseases antibody-producing PC are thought to reside in 
large numbers inside the spleen and LN, presumably in stable niches and 
contributing to pathogenesis. In such disease types, treatment with anti-CD20 
antibodies (rituximab) often does not efficiently deplete PC (43, 44). In contrast, 
therapies based on blocking BAFF/APRIL (Atacicept) or IL-6 have proven to be 
effective in reducing autoantibody levels and thereby autoimmune pathology (45, 46). 
These findings suggest that fibroblastic cells or their products are an interesting 
therapeutic target. Using this approach, pathological immune effector cells could be 
eliminated by destroying their survival niche. Conversely, boosting PC niches within 
LN, spleen or bone marrow may be a way of enhancing vaccine-induced humoral 
responses and memory. 
 
 
EXPERIMENTAL PROCEDURES 
Mice and Immunization 
C57BL/6 mice were from Harlan Olac. OT-I and OT-II mice from the Jackson 
laboratory (bred to CD45.1+ B6 mice). Other mice used were pCol-GFP transgenic 
(27), IL-6 knockout (39), BAFF knockout (47), non-cleavable BAFF transgenic (48), 
plt/plt (16). One million cells from LN and spleen of OT-I and OT-II mice were 
injected i.v. into recipient mice which were immunized the following day s.c. with 50 
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µl OVA/Mont (1 mg/ml ovalbumin (OVA, Sigma) containing 25% of Montanide ISA 25 
(Seppic, France)) above areas drained by inguinal, axillary, and brachial LN (6 
injections per mouse) (25). Alternatively, mice were immunized the same way with 50 
µl of sheep red blood cells (SRBC) (Eurobio, France) leading to a comparable PC 
response. All mouse experiments were authorized by the Swiss Federal Veterinary 
Office (authorization number 1612.2) and by the animal experimentation ethic 
committee of University Paris Descartes, Paris, France (CEEA34.ED.042.12).  
 
FRC isolation  
Peripheral LN (pLN; axillary, brachial and inguinal) were dissected from sacrificed 
mice, cut into small pieces and digested for 30 min at 37°C with gentle stirring in 1.5 
ml DMEM medium (Gibco) containing collagenase IV (3 mg/ml; Worthington), DNAse 
I (40 µg/ml; Roche), CaCl2 (3 mM) and 2% (vol/vol) FCS (16). Cells were then 
passed through a 40 µm strainer (Becton Dickinson), washed twice and resuspended 
in DMEM/2% FCS.  
 
Flow cytometry and cell sorting  
Cells were labeled as described previously (25) using Abs listed in SI Appendix 
Table S1. Intracellular staining of chemokines was performed on surface marked 
cells fixed with 2% PFA, then permeabilized and stained in 0.1% saponin in PBS. 
Rabbit anti-CCL21 and Goat anti-CXCL13 were detected with Alexa 488 or 647 
coupled secondary antibodies. Data were acquired on a LSRII (BD Biosystems) and 
analyzed with FlowJo (TreeStar). Cells were sorted with a FACSAria Ib for RNA 
isolation directly into lysis buffer (RNeasy micro kit, Qiagen) or for cell culture into 
complete RPMI medium (Gibco). 
 
MACS purification and survival assays of plasmablasts and plasma cells 
pLN of mice (OVA/Mont d6.5) passed through a 40 µm mesh were depleted of naïve 
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lymphocytes by panning (B220, TCR), then cell suspensions stained with anti-
CD138 PE or biotin followed by anti-PE or Streptavidin magnetic beads, respectively, 
and finally enriched by magnetic-activated cell sorting (MACS; purity of 90-95%). 
Occasionally, they were labelled with 5nM CSFE before the enrichment. Sorted 
stromal or hematopoietic cells were cultured overnight in 96-well plates followed by 
adding purified PC at approximately a 5-10 fold higher number (1.2 x 104 or 6 x 104) 
and if indicated inhibitors: IL-6 (MP5-20F3, BioXcell), APRIL (Apry-1-1, Adipogen), 
APRIL and BAFF (hTACI-Fc, Adipogen) or AMD3100 (inhibitor of CXCR4, Sigma). 
After 3 days, surviving PC numbers were determined by FACS.  
 
ELISA measurements of OVA-specific IgM and IgG, and of IL-6 protein levels 
Flat-bottom 96 well MaxiSorp plates (Nunc) were coated with 5 µg/mL OVA and 
blocked with 1% BSA in PBS. Serial dilutions of samples were added for 1 h and 
bound antibody detected with biotinylated goat anti-mouse IgM or IgG (Invitrogen) 
followed by HRP-conjugated streptavidin (Jackson). Color development using TMB 
solution (Sigma) was measured at 450 nm with correction set at 550 nm. Relative 
antibody concentrations correspond to the dilution giving an OD of 50%. IL-6 protein 
level was measured in the supernatant of cultured cells, according to the kit’s 
instructions (eBioscience). 
 
RNA isolation and quantitative real-time PCR  
RNA was extracted using the RNeasy micro kit (Qiagen). First-strand cDNA 
synthesis, quantitative real-time PCR, primers and normalization were as described 
previously (16) or shown in SI Appendix Table S2.  
 
Immunofluorescence labeling of tissue sections 
For murine tissue blocks, cryosections (8 µm) and labeling of naïve or OVA/Mont 
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activated pLN were as previously described (16). For details on antibodies see 
the SI Appenix Table S1. Human pLN were obtained from transplant patients 
(ethics permit: CA/5192) and 5 m cryostat sections acetone-fixed before staining. 
See SI appendix for more details. 
 
In situ hybridization 
The Ccl19, Ccl21, Cxcl13, and Cxcl12 ‘riboprobe’ was cloned and used as 
described (16, 49). The nucleotides 35 to 767 of Il6 (NM_031168.1) were used as 
a template for making a riboprobe. Cryosections of pLN were treated as 
previously described (16). After in situ hybridization, tissue sections were stained 
with antibodies to B220 and laminin followed by fluorochrome-labeled secondary 
antibodies. 
 
Microscopy and image analysis 
Images were acquired either with an upright Zeiss Axioplan, a Zeiss SP5 confocal 
or a Leica DMI6000 spinning-disk confocal microscope. Images were treated 
using ImageJ (NIH), Adobe Photoshop or Imaris (Bitplane). Imaging of fibrillar 
collagen within LN of pCol-GFP mice was performed using SHG microscopy. To 
detect FRC-PC contacts, the colocalization tool in Imaris was used. Three-
dimensional (3D) reconstruction of sequential z series was performed using the 
surface tool of Imaris. For additional information see SI appendix. 
 
Imaging of plasma cell motility within live LN slices 
Live vibratome sections were stained for 15 minutes at 37°C with APC-conjugated 
anti-CD138 (281.2) and washed thereafter. In some experiments, pCol-GFP mice 
were treated with either IL-6 neutralizing (MP5-20F3, 10µg/mL) or control antibodies 
at day 2 and day 5 after SRBC immunization. For details see SI appendix.  
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Statistical analysis 
Statistical analysis was determined with an unpaired two-tailed Student’s t-test or 
one way ANOVA by Prism 5 (GraphPad). *, p<0.05; **, p<0.01; ***, p<0.001. 
Detailed experimental procedures can be found in the SI appendix. 
 
SUPPLEMENTAL INFORMATION APPENDIX 
Supplemental information includes additional experimental procedures, seven figures, 
seven movies, two additional tables, references, and can be found as pdf file with 
this article online. 
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FIGURE LEGENDS 
Fig. 1. Histological identification and characterization of a new FRC subset 
colocalizing with plasma cells in medullary cords of activated lymph nodes. 
Immunofluorescence microscopy of sections from pLN of naïve or OVA/Mont-
immunized mice (A-D), or on sections from human pLN (E-G). (A and B) Cryostat 
sections stained for FRC (pdpn+LYVE1-), lymphatic vessels (pdpn+LYVE1+), CD3+ T 
cells, B220+ B cells and CD138+ PC. (C-D) Vibratome and cryostat sections of LN 
stained with indicated antibodies. (E-G) Sections of human pLN were stained for the 
indicated markers, with a focus on lymphoid compartments and vascular cells (E), 
fibroblastic cells (F) and extracellular matrix components (G).  Boxed areas are 
shown at higher magnification in the right or the row below. Dashed lines indicating 
examples of MC where PC reside. Arrows point to representative FRC within a given 
zone. B, B cell zone (follicle); T, T cell zone; M, medulla; MC, medullary cords, MS, 
medullary sinus, SCS, subcapsular sinus; scale bar, 100µm. Results are 
representative for at least three independent mice or human samples. 
 
Fig. 2. Medullary FRC have a unique phenotype and cytokine profile and expand in 
number during lymph node swelling. (A-D) FACS analysis of CD45-CD35- cells from 
pLN of naive or OVA/Mont-immunized mice at the indicated time points. (A) Dot plots 
in upper row show the gating of FRC (pdpn+CD31-) versus BEC (pdpn-CD31+) and 
LEC (pdpn+CD31+) from naïve pLN. The expression of MAdCAM and BP3 in FRC 
allows to distinguish three FRC subpopulations: MRC, TRC, and MedRC. Shown on 
the right side is the control staining when anti-MAdCAM antibody was not added. Dot 
plots in lower row show a representative staining of the 3 FRC subsets in naïve 
versus activated LN, with the percentages indicated for of each population (n≥3). (B) 
Number of total FRC and of each of the three FRC subsets per pLN upon 
immunization. (C) Representative histograms showing the level of BrdU incorporation 
in the three FRC subsets (OVA/Mont d5.5). Numbers indicate the percentage of 
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BrdU+ cells. Black line: anti-BrdU antibody; dashed line: isotype control antibody on 
total FRC. (D) Representative histograms displaying the frequency of CCL21- and 
CXCL13-expressing cells among the three FRC subsets found in activated pLN. 
Black line: specific antibody; dashed line: no primary antibody on total FRC. (E) The 
three FRC subsets and CD31+ cells (LEC/BEC) were sorted from activated pLN and 
normalized transcript levels of indicated cytokine transcripts measured by qRT-PCR 
(means±SD, n=4). (F) ISH analysis for indicated cytokine transcripts (green) or the 
sense control (for CXCL12). (G) pLN sections stained with the indicated antibodies. 
The boxed areas are represented below at higher magnification.  (H) Multiparameter 
flow cytometry based clustering of FRC (CD45-31-pdpn+) subsets from naïve pLN 
using the TSNe algorithms (Flowjo) to display 7 parameters (FCS, SSC, Pdpn, BP3, 
MAdCAM-1, CXCL13 and CCL21) in a 2D representation. Colored areas were added 
manually. Scale bar, 100µm. Results in A-D and F-G are representative for at least 
three independent mice. *p<0.05, **p<0.01, *** p<0.001.  
 
Fig. 3. Medullary FRC produce a dense matrix network and only partially associate 
with it. (A) Immunofluorescence microscopy of activated pLN (OVA/Mont d8.5) for 
the indicated antibodies. The boxed area is represented in the middle panel at higher 
magnification and with single colors. On the right side is shown a vibratome section 
of the LN medulla. (B) The levels of collagen 11 and collagen 12 transcripts are 
shown for the indicated cell types isolated from either naive or activated (OVA/Mont 
d5.5) pLN (means±SD, n=4). (C-E) Confocal images of vibratome sections of pLN 
(SRBC d7) from pCol-GFP mice and stained with the indicated antibodies. (D) 
Histogram showing the fluorescence intensity of each marker along the dashed line 
shown on middle panels. (E) The boxed areas are represented below at higher 
magnification and showing only the GFP+ fibroblasts either in T zone or medulla. 
Graphs on the right show the GFP fluorescence intensity of FRC found in these two 
zones, their concentration, as well as the width and spacing between fibroblast 
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protrusions. (F) Two-photon microscopy images of naive and activated pLN (SRBC 
d7) from pCol-GFP mice showing GFP expression and SHG highlighting collagen 
fibers. (G) 3D reconstruction of two-photon images displaying T zones and MC of 
naive LN. See also SI Appendix Movie S1. (H) Vibratome section of pLN (OVA/Mont 
d5.5) 10 min after s.c. injection of Texas Red (TR)-dextran and stained with the 
antibodies indicated. The boxed areas are represented on the right at higher 
magnification.  
 
Fig. 4: Medullary FRC are a major component of the plasma cell niche. (A-B) 
Immunofluorescence images of activated pLN with MC areas being highlighted. (A) 
Confocal microscopy of activated pLN (SRBC d7) from pCol-GFP mice stained with 
the antibodies indicated. Right: Frequency of PC in contact with F4/80+ and B220+ 
cells. Values are mean ± SD of 3-5 experiments in which conjugates were scored 
from 6-9 LN slices. (B-C) Localization and migration of endogenous PB/PC in 
vibratome sections of viable activated pLN from pCol-GFP mice. (B) Tracks of 
individual endogenous PB/PC in relation to GFP+ FRC. Tracks are color coded 
according to the extent of PB/PC displacement. Graphs on right side show velocities 
and displacement lengths of PB/PC. Values are from 3 experiments in which cells 
were monitored from 3-5 LN slices. See also SI Appendix Movie S3. (C) Motile 
behavior of PB/PC relative to GFP+ FRC. Top panels: Snapshots are shown at 
various time intervals for the same zone and cells. The trajectory of PB/PC in the 
outer T zone was superimposed over fluorescence images. See also SI Appendix 
Movie S4 and S5. Bottom left panel: Graphic representation of interactions between 
PB/PC and GFP+ FRC. Each row corresponds to an individual PB/PC, and the 
periods of contact with FRC are colored with different shades of green corresponding 
to different FRC partners and white corresponding to no FRC partner being visible. 
Graph on bottom right side summarizes the average contact time of PB/PC with their 
FRC partners.  
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Fig. 5. Medullary FRC express high levels of plasma cell survival factors. Mice were 
immunized with OVA/Mont and the expression of PC survival factors analyzed in 
draining pLN. (A) The transcript levels of baff, april, il6 and cxcl12 was assessed in 
cells sorted from fully digested pLN as shown in Fig. 2A and SI Appendix Fig. S5A. 
T/B lymphocytes were CD19+ or TCR+. (means±SEM, naïve n=2, OVA n=4). (B) 
Immunofluorescence staining of activated pLN from wt, uncleavable BAFF transgenic 
and BAFF KO mice for BAFF expression (red) on FRC and LEC in medulla. Arrows 
point to BAFF+ TRC and MedRC. Stars indicate staining artifacts due to high 
endogenous HRP in BAFF KO mice. n=3. (C) ISH analysis of il6 transcript or the 
sense control. The boxed areas are represented at higher magnification in the row 
below. Scale bar, 100µm. n=3. (D) ELISA for IL-6 protein levels in the supernatant of 
the indicated cell types sorted from d5 ova/Mont immunized pLN and cultured for 18h. 
Values were normalized for 10’000 cells. n=4-9. Number of experiments: 1 (A), 2 (D), 
2-4 (B, C). 
 
Fig. 6: IL-6 drives plasma cell survival but not homing in activated lymph nodes. Cell 
suspensions of pLN from wt or IL-6 KO mice (OVA/Mont d0, d5.5 or d8.5) were either 
analyzed ex vivo by FACS for the number of PC and intracellular IgG+ PC per pLN (A) 
or for the titer of OVA-specific IgM/G measured in the supernatant of total pLN cells 
cultured for 3 days (B), n=7-13. Localization (C) and motility (D; velocity and 
displacement length) of endogenous PC/PB were monitored by time-lapse confocal 
microscopy in live vibratome slices from activated (SRBC d6) pLN of pCol-GFP mice 
treated either with neutralizing antibodies to IL-6 (anti-IL-6) or control antibodies (Ctrl). 
TZ, T zone; n=6 mice. Number of pooled experiments: 6 (A-B), 2 (C, D). See also SI 
Appendix Movie S7 and Fig. S6. 
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Fig. 7: Medullary FRC, together with macrophages and dendritic cells, promote PC 
survival with a major role for IL-6. Activated pLN (OVA/Mont d5-6) were used for 
MACS-isolation of PB/PC and FACS-sorting of potential support cells. PB/PC were 
cultured for 3 days in the indicated conditions followed by the analysis of surviving 
PCs by FACS (B220low/-CD138+CD44+IgM-FSChiSSChi) or of IgM/G antibody titers by 
ELISA.  (A) Number of surviving PC after culture in presence of rIL-6, a monolayer of 
total FRC from d5.5 activated pLN (act.FRC), conditioned medium (CM) from total 
act.FRC cultured for 3 days, or in presence of a transwell separating act. FRC from 
PC. (B) Number of surviving PC after culture in presence or absence of GM-CSF (to 
improve myeloid cell survival) or of a layer of the indicated cells. (C-E) PC number 
and IgM/G titers after cocultures in presence or absence of IL-6 neutralizing antibody 
or rIL-6; with or without MedRC (C); macrophages (Mac) or DC (D); in presence or 
not of GM-CSF along with the indicated cell type(s) (E). Gr, granulocytes. Error bars 
present SD (n=3-8); */# p<0.05, **/## p<0.01, ***/### p<0.001; in (F): *, compared with 
PC cultured with medium only (first column); #, compared with PC cultured with 
MedRC/Mac/DC/Gr (last column). Shown results are representative for 2 (A, C-E) or 
5 (B) independent experiments. 
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